RT Journal Article
SR Electronic
T1 Projections for first-wave COVID-19 deaths across the US using social-distancing measures derived from mobile phones
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.16.20068163
DO 10.1101/2020.04.16.20068163
A1 Woody, Spencer
A1 Tec, Mauricio
A1 Dahan, Maytal
A1 Gaither, Kelly
A1 Lachmann, Michael
A1 Fox, Spencer J.
A1 Meyers, Lauren Ancel
A1 Scott, James
A1 ,
YR 2020
UL http://medrxiv.org/content/early/2020/04/26/2020.04.16.20068163.abstract
AB We propose a Bayesian model for projecting first-wave COVID-19 deaths in all 50 U.S. states. Our model’s projections are based on data derived from mobile-phone GPS traces, which allows us to estimate how social-distancing behavior is “flattening the curve” in each state. In a two-week look-ahead test of out-of-sample forecasting accuracy, our model significantly outperforms the widely used model from the Institute for Health Metrics and Evaluation (IHME), achieving 42% lower prediction error: 13.2 deaths per day average error across all U.S. states, versus 22.8 deaths per day average error for the IHME model. Our model also provides an accurate, if slightly conservative, assessment of forecasting accuracy: in the same look-ahead test, 98% of data points fell within the model’s 95% credible intervals. Our model’s projections are updated daily at https://covid-19.tacc.utexas.edu/projections/.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was partially funded by grants from the National Science Foundation, the National Institutes of Health, and by a gift from Tito’s Handmade Vodka to the UT COVID-19 Modeling Consortium.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData on COVID-19 deaths were provided by the New York Times and are publicly available: https://github.com/nytimes/covid-19-data/ Data on social-distancing metrics were provided under a Data Use Agreement by SafeGraph and are available by contacting SafeGraph directly: https://www.safegraph.com/dashboard/covid19-shelter-in-place https://github.com/nytimes/covid-19-data/ https://www.safegraph.com